SEC Filing Summary: pSivida Limited (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by pSivida Limited, a foreign issuer with principal executive offices in Perth, Western Australia, on October 27, 2005. The report covers the month of October 2005. The registrant files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure of a specific corporate event rather than a financial statement.
Material Changes
The primary material event disclosed in this filing is the acquisition of a license, identified in the exhibit index as the "Beijing Med-Pharm Licence" (Exhibit 99.1). No financial comparisons to prior periods are included in this document.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for management guidance, future outlook, specific risk factors, contingencies, or unusual items beyond the disclosure of the license acquisition.
Key Facts for Investor Verification
- Verify the terms and scope of the Beijing Med-Pharm Licence referenced in Exhibit 99.1.
- Confirm the strategic impact of this license on pSivida Limited's operations in China.
- Review subsequent Form 20-F filings for financial performance data not included in this 6-K.